000 | 01951 a2200577 4500 | ||
---|---|---|---|
005 | 20250514204639.0 | ||
264 | 0 | _c20050106 | |
008 | 200501s 0 0 eng d | ||
022 | _a0732-8893 | ||
024 | 7 |
_a10.1016/j.diagmicrobio.2004.06.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaddley, John W | |
245 | 0 | 0 |
_aUtility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia. _h[electronic resource] |
260 |
_bDiagnostic microbiology and infectious disease _cOct 2004 |
||
300 |
_a119-24 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBacteriological Techniques |
650 | 0 | 4 |
_aCandida _xclassification |
650 | 0 | 4 |
_aCandidiasis _xdiagnosis |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluconazole _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFungemia _xdiagnosis |
650 | 0 | 4 | _aHospitals, University |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPatel, Mukesh | |
700 | 1 | _aJones, Marga | |
700 | 1 | _aCloud, Gretchen | |
700 | 1 | _aSmith, Anita C | |
700 | 1 | _aMoser, Stephen A | |
773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 50 _gno. 2 _gp. 119-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diagmicrobio.2004.06.004 _zAvailable from publisher's website |
999 |
_c15165756 _d15165756 |